Novel Vaccine Delivery Systems and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Novel Vaccine Delivery Systems Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Novel Vaccine Delivery Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Novel Vaccine Delivery Systems Overall Market Size
2.1 Global Novel Vaccine Delivery Systems Market Size: 2022 VS 2032
2.2 Global Novel Vaccine Delivery Systems Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Novel Vaccine Delivery Systems Players in Global Market
3.2 Top Global Novel Vaccine Delivery Systems Companies Ranked by Revenue
3.3 Global Novel Vaccine Delivery Systems Revenue by Companies
3.4 Top 3 and Top 5 Novel Vaccine Delivery Systems Companies in Global Market, by Revenue in 2022
3.5 Global Companies Novel Vaccine Delivery Systems Product Type
3.6 Tier 1, Tier 2 and Tier 3 Novel Vaccine Delivery Systems Players in Global Market
3.6.1 List of Global Tier 1 Novel Vaccine Delivery Systems Companies
3.6.2 List of Global Tier 2 and Tier 3 Novel Vaccine Delivery Systems Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Novel Vaccine Delivery Systems Market Size Markets, 2022 & 2032
4.1.2 Intramuscular Delivery
4.1.3 Intramuscular Delivery
4.1.4 Others
4.2 By Type - Global Novel Vaccine Delivery Systems Revenue & Forecasts
4.2.1 By Type - Global Novel Vaccine Delivery Systems Revenue, 2018-2023
4.2.2 By Type - Global Novel Vaccine Delivery Systems Revenue, 2024-2032
4.2.3 By Type - Global Novel Vaccine Delivery Systems Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Novel Vaccine Delivery Systems Market Size, 2022 & 2032
5.1.2 Hospitals & Clinics
5.1.3 Research Institutes
5.1.4 Others
5.2 By Application - Global Novel Vaccine Delivery Systems Revenue & Forecasts
5.2.1 By Application - Global Novel Vaccine Delivery Systems Revenue, 2018-2023
5.2.2 By Application - Global Novel Vaccine Delivery Systems Revenue, 2024-2032
5.2.3 By Application - Global Novel Vaccine Delivery Systems Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Novel Vaccine Delivery Systems Market Size, 2022 & 2032
6.2 By Region - Global Novel Vaccine Delivery Systems Revenue & Forecasts
6.2.1 By Region - Global Novel Vaccine Delivery Systems Revenue, 2018-2023
6.2.2 By Region - Global Novel Vaccine Delivery Systems Revenue, 2024-2032
6.2.3 By Region - Global Novel Vaccine Delivery Systems Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Novel Vaccine Delivery Systems Revenue, 2018-2032
6.3.2 US Novel Vaccine Delivery Systems Market Size, 2018-2032
6.3.3 Canada Novel Vaccine Delivery Systems Market Size, 2018-2032
6.3.4 Mexico Novel Vaccine Delivery Systems Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Novel Vaccine Delivery Systems Revenue, 2018-2032
6.4.2 Germany Novel Vaccine Delivery Systems Market Size, 2018-2032
6.4.3 France Novel Vaccine Delivery Systems Market Size, 2018-2032
6.4.4 U.K. Novel Vaccine Delivery Systems Market Size, 2018-2032
6.4.5 Italy Novel Vaccine Delivery Systems Market Size, 2018-2032
6.4.6 Russia Novel Vaccine Delivery Systems Market Size, 2018-2032
6.4.7 Nordic Countries Novel Vaccine Delivery Systems Market Size, 2018-2032
6.4.8 Benelux Novel Vaccine Delivery Systems Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Novel Vaccine Delivery Systems Revenue, 2018-2032
6.5.2 China Novel Vaccine Delivery Systems Market Size, 2018-2032
6.5.3 Japan Novel Vaccine Delivery Systems Market Size, 2018-2032
6.5.4 South Korea Novel Vaccine Delivery Systems Market Size, 2018-2032
6.5.5 Southeast Asia Novel Vaccine Delivery Systems Market Size, 2018-2032
6.5.6 India Novel Vaccine Delivery Systems Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Novel Vaccine Delivery Systems Revenue, 2018-2032
6.6.2 Brazil Novel Vaccine Delivery Systems Market Size, 2018-2032
6.6.3 Argentina Novel Vaccine Delivery Systems Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Novel Vaccine Delivery Systems Revenue, 2018-2032
6.7.2 Turkey Novel Vaccine Delivery Systems Market Size, 2018-2032
6.7.3 Israel Novel Vaccine Delivery Systems Market Size, 2018-2032
6.7.4 Saudi Arabia Novel Vaccine Delivery Systems Market Size, 2018-2032
6.7.5 UAE Novel Vaccine Delivery Systems Market Size, 2018-2032
7 Novel Vaccine Delivery Systems Companies Profiles
7.1 Altaris Capital Partners
7.1.1 Altaris Capital Partners Company Summary
7.1.2 Altaris Capital Partners Business Overview
7.1.3 Altaris Capital Partners Novel Vaccine Delivery Systems Major Product Offerings
7.1.4 Altaris Capital Partners Novel Vaccine Delivery Systems Revenue in Global Market (2018-2023)
7.1.5 Altaris Capital Partners Key News & Latest Developments
7.2 Kindeva Drug Delivery
7.2.1 Kindeva Drug Delivery Company Summary
7.2.2 Kindeva Drug Delivery Business Overview
7.2.3 Kindeva Drug Delivery Novel Vaccine Delivery Systems Major Product Offerings
7.2.4 Kindeva Drug Delivery Novel Vaccine Delivery Systems Revenue in Global Market (2018-2023)
7.2.5 Kindeva Drug Delivery Key News & Latest Developments
7.3 Becton
7.3.1 Becton Company Summary
7.3.2 Becton Business Overview
7.3.3 Becton Novel Vaccine Delivery Systems Major Product Offerings
7.3.4 Becton Novel Vaccine Delivery Systems Revenue in Global Market (2018-2023)
7.3.5 Becton Key News & Latest Developments
7.4 Dickinson,
7.4.1 Dickinson, Company Summary
7.4.2 Dickinson, Business Overview
7.4.3 Dickinson, Novel Vaccine Delivery Systems Major Product Offerings
7.4.4 Dickinson, Novel Vaccine Delivery Systems Revenue in Global Market (2018-2023)
7.4.5 Dickinson, Key News & Latest Developments
7.5 Carl Zeiss Foundation
7.5.1 Carl Zeiss Foundation Company Summary
7.5.2 Carl Zeiss Foundation Business Overview
7.5.3 Carl Zeiss Foundation Novel Vaccine Delivery Systems Major Product Offerings
7.5.4 Carl Zeiss Foundation Novel Vaccine Delivery Systems Revenue in Global Market (2018-2023)
7.5.5 Carl Zeiss Foundation Key News & Latest Developments
7.6 Gerresheimer AG
7.6.1 Gerresheimer AG Company Summary
7.6.2 Gerresheimer AG Business Overview
7.6.3 Gerresheimer AG Novel Vaccine Delivery Systems Major Product Offerings
7.6.4 Gerresheimer AG Novel Vaccine Delivery Systems Revenue in Global Market (2018-2023)
7.6.5 Gerresheimer AG Key News & Latest Developments
7.7 Corium International
7.7.1 Corium International Company Summary
7.7.2 Corium International Business Overview
7.7.3 Corium International Novel Vaccine Delivery Systems Major Product Offerings
7.7.4 Corium International Novel Vaccine Delivery Systems Revenue in Global Market (2018-2023)
7.7.5 Corium International Key News & Latest Developments
7.8 Inovio Pharmaceuticals
7.8.1 Inovio Pharmaceuticals Company Summary
7.8.2 Inovio Pharmaceuticals Business Overview
7.8.3 Inovio Pharmaceuticals Novel Vaccine Delivery Systems Major Product Offerings
7.8.4 Inovio Pharmaceuticals Novel Vaccine Delivery Systems Revenue in Global Market (2018-2023)
7.8.5 Inovio Pharmaceuticals Key News & Latest Developments
7.9 Bioject Medical Technologies
7.9.1 Bioject Medical Technologies Company Summary
7.9.2 Bioject Medical Technologies Business Overview
7.9.3 Bioject Medical Technologies Novel Vaccine Delivery Systems Major Product Offerings
7.9.4 Bioject Medical Technologies Novel Vaccine Delivery Systems Revenue in Global Market (2018-2023)
7.9.5 Bioject Medical Technologies Key News & Latest Developments
7.10 PharmaJet
7.10.1 PharmaJet Company Summary
7.10.2 PharmaJet Business Overview
7.10.3 PharmaJet Novel Vaccine Delivery Systems Major Product Offerings
7.10.4 PharmaJet Novel Vaccine Delivery Systems Revenue in Global Market (2018-2023)
7.10.5 PharmaJet Key News & Latest Developments
7.11 Retractable Technologies
7.11.1 Retractable Technologies Company Summary
7.11.2 Retractable Technologies Business Overview
7.11.3 Retractable Technologies Novel Vaccine Delivery Systems Major Product Offerings
7.11.4 Retractable Technologies Novel Vaccine Delivery Systems Revenue in Global Market (2018-2023)
7.11.5 Retractable Technologies Key News & Latest Developments
7.12 Terumo Corporation
7.12.1 Terumo Corporation Company Summary
7.12.2 Terumo Corporation Business Overview
7.12.3 Terumo Corporation Novel Vaccine Delivery Systems Major Product Offerings
7.12.4 Terumo Corporation Novel Vaccine Delivery Systems Revenue in Global Market (2018-2023)
7.12.5 Terumo Corporation Key News & Latest Developments
7.13 VAXXAS
7.13.1 VAXXAS Company Summary
7.13.2 VAXXAS Business Overview
7.13.3 VAXXAS Novel Vaccine Delivery Systems Major Product Offerings
7.13.4 VAXXAS Novel Vaccine Delivery Systems Revenue in Global Market (2018-2023)
7.13.5 VAXXAS Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Novel Vaccine Delivery Systems Market Opportunities & Trends in Global Market
Table 2. Novel Vaccine Delivery Systems Market Drivers in Global Market
Table 3. Novel Vaccine Delivery Systems Market Restraints in Global Market
Table 4. Key Players of Novel Vaccine Delivery Systems in Global Market
Table 5. Top Novel Vaccine Delivery Systems Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Novel Vaccine Delivery Systems Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Novel Vaccine Delivery Systems Revenue Share by Companies, 2018-2023
Table 8. Global Companies Novel Vaccine Delivery Systems Product Type
Table 9. List of Global Tier 1 Novel Vaccine Delivery Systems Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Novel Vaccine Delivery Systems Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Novel Vaccine Delivery Systems Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Novel Vaccine Delivery Systems Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Novel Vaccine Delivery Systems Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Novel Vaccine Delivery Systems Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Novel Vaccine Delivery Systems Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Novel Vaccine Delivery Systems Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2024-2032
Table 30. Altaris Capital Partners Company Summary
Table 31. Altaris Capital Partners Novel Vaccine Delivery Systems Product Offerings
Table 32. Altaris Capital Partners Novel Vaccine Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 33. Altaris Capital Partners Key News & Latest Developments
Table 34. Kindeva Drug Delivery Company Summary
Table 35. Kindeva Drug Delivery Novel Vaccine Delivery Systems Product Offerings
Table 36. Kindeva Drug Delivery Novel Vaccine Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 37. Kindeva Drug Delivery Key News & Latest Developments
Table 38. Becton Company Summary
Table 39. Becton Novel Vaccine Delivery Systems Product Offerings
Table 40. Becton Novel Vaccine Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 41. Becton Key News & Latest Developments
Table 42. Dickinson, Company Summary
Table 43. Dickinson, Novel Vaccine Delivery Systems Product Offerings
Table 44. Dickinson, Novel Vaccine Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 45. Dickinson, Key News & Latest Developments
Table 46. Carl Zeiss Foundation Company Summary
Table 47. Carl Zeiss Foundation Novel Vaccine Delivery Systems Product Offerings
Table 48. Carl Zeiss Foundation Novel Vaccine Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 49. Carl Zeiss Foundation Key News & Latest Developments
Table 50. Gerresheimer AG Company Summary
Table 51. Gerresheimer AG Novel Vaccine Delivery Systems Product Offerings
Table 52. Gerresheimer AG Novel Vaccine Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 53. Gerresheimer AG Key News & Latest Developments
Table 54. Corium International Company Summary
Table 55. Corium International Novel Vaccine Delivery Systems Product Offerings
Table 56. Corium International Novel Vaccine Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 57. Corium International Key News & Latest Developments
Table 58. Inovio Pharmaceuticals Company Summary
Table 59. Inovio Pharmaceuticals Novel Vaccine Delivery Systems Product Offerings
Table 60. Inovio Pharmaceuticals Novel Vaccine Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 61. Inovio Pharmaceuticals Key News & Latest Developments
Table 62. Bioject Medical Technologies Company Summary
Table 63. Bioject Medical Technologies Novel Vaccine Delivery Systems Product Offerings
Table 64. Bioject Medical Technologies Novel Vaccine Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 65. Bioject Medical Technologies Key News & Latest Developments
Table 66. PharmaJet Company Summary
Table 67. PharmaJet Novel Vaccine Delivery Systems Product Offerings
Table 68. PharmaJet Novel Vaccine Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 69. PharmaJet Key News & Latest Developments
Table 70. Retractable Technologies Company Summary
Table 71. Retractable Technologies Novel Vaccine Delivery Systems Product Offerings
Table 72. Retractable Technologies Novel Vaccine Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 73. Retractable Technologies Key News & Latest Developments
Table 74. Terumo Corporation Company Summary
Table 75. Terumo Corporation Novel Vaccine Delivery Systems Product Offerings
Table 76. Terumo Corporation Novel Vaccine Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 77. Terumo Corporation Key News & Latest Developments
Table 78. VAXXAS Company Summary
Table 79. VAXXAS Novel Vaccine Delivery Systems Product Offerings
Table 80. VAXXAS Novel Vaccine Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 81. VAXXAS Key News & Latest Developments
List of Figures
Figure 1. Novel Vaccine Delivery Systems Segment by Type in 2022
Figure 2. Novel Vaccine Delivery Systems Segment by Application in 2022
Figure 3. Global Novel Vaccine Delivery Systems Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Novel Vaccine Delivery Systems Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Novel Vaccine Delivery Systems Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Novel Vaccine Delivery Systems Revenue in 2022
Figure 8. By Type - Global Novel Vaccine Delivery Systems Revenue Market Share, 2018-2032
Figure 9. By Application - Global Novel Vaccine Delivery Systems Revenue Market Share, 2018-2032
Figure 10. By Type - Global Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Novel Vaccine Delivery Systems Revenue Market Share, 2018-2032
Figure 12. By Application - Global Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Novel Vaccine Delivery Systems Revenue Market Share, 2018-2032
Figure 14. By Region - Global Novel Vaccine Delivery Systems Revenue Market Share, 2018-2032
Figure 15. By Country - North America Novel Vaccine Delivery Systems Revenue Market Share, 2018-2032
Figure 16. US Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Novel Vaccine Delivery Systems Revenue Market Share, 2018-2032
Figure 20. Germany Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 21. France Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Novel Vaccine Delivery Systems Revenue Market Share, 2018-2032
Figure 28. China Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 32. India Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Novel Vaccine Delivery Systems Revenue Market Share, 2018-2032
Figure 34. Brazil Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Novel Vaccine Delivery Systems Revenue Market Share, 2018-2032
Figure 37. Turkey Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2018-2032
Figure 41. Altaris Capital Partners Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Kindeva Drug Delivery Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Becton Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Dickinson, Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Carl Zeiss Foundation Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Gerresheimer AG Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Corium International Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Inovio Pharmaceuticals Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bioject Medical Technologies Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. PharmaJet Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Retractable Technologies Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Terumo Corporation Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. VAXXAS Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
